Literature DB >> 15160386

Effect of hyperbaric oxygen therapy on nerve regeneration in early diabetes.

Atakan Aydin1, Burcu Celet Ozden, Sacit Karamürsel, Seyhun Solakoğlu, Samil Aktaş, Metin Erer.   

Abstract

Nerve regeneration in diabetes is essential for reversal of neuropathy as well as the recovery of nerves from injury due to acute nerve compression and entrapment. Endoneural hypoxia due to hyperglycemia-induced blood flow reductions is observed early in the course of diabetes, and the resultant ischemia plays a role in the diminished neural regeneration. Hyperbaric oxygen therapy is capable of producing tissue hyperoxia by raising oxygen tensions in ischemic tissues, and was shown to be beneficial in the reversal of experimental ischemic neuropathy. In this study, an experimental diabetes model was used to evaluate the functional and histomorphological effects of hyperbaric oxygen therapy on early diabetic nerve regeneration. Our results indicate that there is significant histomorphological impairment of nerve regeneration, even in very early stages of diabetes. However, no beneficial effects of hyperbaric oxygen therapy could be demonstrated at this stage. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15160386     DOI: 10.1002/micr.20038

Source DB:  PubMed          Journal:  Microsurgery        ISSN: 0738-1085            Impact factor:   2.425


  3 in total

Review 1.  A review on the neuroprotective effects of hyperbaric oxygen therapy.

Authors:  Fahimeh Ahmadi; Ali Reza Khalatbary
Journal:  Med Gas Res       Date:  2021 Apr-Jun

2.  COMSOL Multiphysics® modelling of oxygen diffusion through a cellulose nanofibril conduit employed for peripheral nerve repair.

Authors:  Julia Towne; Nicklaus Carter; David J Neivandt
Journal:  Biomed Eng Online       Date:  2021-06-15       Impact factor: 2.819

Review 3.  Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets.

Authors:  Reddemma Sandireddy; Veera Ganesh Yerra; Aparna Areti; Prashanth Komirishetty; Ashutosh Kumar
Journal:  Int J Endocrinol       Date:  2014-04-30       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.